IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2019)

IDEAYA Biosciences' (IDYA) quarterly Interest & Investment Income came in at $536000.0 in Q4 2019, down 6.13% year-on-year from $571000.0 in Q4 2018, and down 18.04% quarter-over-quarter from $654000.0 in Q3 2019.

IDEAYA Biosciences (IDYA) Interest & Investment Income (2018 - 2019) Analysis & Trends

IDEAYA Biosciences has disclosed Interest & Investment Income across 2 years of filings, most recently posting $536000.0 for Q4 2019.

  • Interest & Investment Income for Q4 2019 came in at $536000.0, down 6.13% year-over-year; the trailing twelve-month figure through Dec 2019 was $2.3 million (changed N/A YoY), and the FY2019 annual result was $2.3 million, up 14.74% from the prior year.
  • Interest & Investment Income came in at $536000.0 for Q4 2019 at IDEAYA Biosciences, down from $654000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $654000.0 in Q3 2019 to a low of $536000.0 in Q4 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 597,319.59
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 40.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 305,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 103,341.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - -14.79 Mn
10 IDEAYA Biosciences 2.78 Bn 2.10 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 536,000.00
Sep 30, 2019 654,000.00
Jun 30, 2019 573,000.00
Dec 31, 2018 571,000.00
Sep 30, 2018 573,000.00
Jun 30, 2018 568,000.00